Optivise Advisory Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,898
Closed -$271K 183
2024
Q2
$271K Buy
+1,898
New +$271K 0.15% 140